Medical equipment mining concept stocks
On the medical equipment mining concept stocks, this article will focus on the medical equipment mining concept stocks, into the collection of ophthalmic medical stocks, collection of news disturbed medical equipment stocks, collection of short medical stocks, collection of medical device stocks, non-collecting leading stocks, to answer the discussion, I hope to be helpful to you.
Medical device procurement concept stocks
Medical device procurement concept stocks include Myriad Medical, Jianfan Biological, Wanbangda, Hua Da Genetics, Hualan Biological, Taigu Pharmaceutical, Medicine Stone Science and Technology, Meikang Biological, Kepu Biological, Thousand Source Pharmaceuticals, International Medicine, Tongtse Medical, Guanhao Biological, Nanfeng Stocks, Weiguang Life, and Zhongyuan Concord, Lepu Medical, TaiLong Pharmaceutical, AnTu Bio, Kangtai Bio, Mike Bio, Hualan Vaccine, Shutai Shen, Willey, Davy Medical, Baichen Pharmaceuticals, Kelen Pharmaceuticals, Jincheng Pharmaceuticals, PharmacyEasy, Chanyuan Pharmaceuticals, PalmReader Technology, Meikang Biologicals, Runda Medical, Matilda Biologicals, Huaping Stocks, Chuangjie Huikang, and so on.
Ophthalmology medical stocks entering the collection
Ophthalmology medical stocks entering the collection include the following:
__Xingqi Ophthalmology: Several ophthalmology medicines such as its products Ciprofloxacin Hydrochloride Eye Drops, Sodium Vitreous Acid Eye Drops, and Oxyfloxacin Ophthalmic Gel have been included in the collection.
__He's Ophthalmology: The company is a platform for the whole ophthalmology industry chain integrating medical treatment, teaching, scientific research and training.
__Prudential Ophthalmology: it specializes in eye health management, mainly carrying out refractive correction, cataract surgery, fundus disease and other ophthalmic disease treatment.
The above ophthalmology medical stocks in the business involved in the sale of glasses and other businesses, if you need help to understand the relevant medical knowledge or investment knowledge, you can ask me questions.
Collective procurement news disturbed the medical equipment stocks fell in general
Recently, the national organization of high-value medical supplies joint procurement office issued a "notice on the second batch of artificial joints centralized banded purchasing in 2023", which means that a new round of centralized banded purchasing of artificial joints is about to start.
By this news, medical equipment stocks fell. Among them, the share price of Myriad Medical, UBM, Lepu Medical, Aide Bio, Chunli Medical, Tongze Medical, Jianfan Bio, Kangtai Bio, Wantai Bio and other companies fell.
So how should investors respond to such market changes? First, investors can pay attention to the fundamental situation of the relevant companies, such as the company's product development capabilities, market competitiveness, profitability and so on. Secondly, investors can pay attention to the impact of national policies on the medical device industry, such as health insurance policies, tax policies, etc. Finally, investors can pay attention to market trends, such as the application of artificial intelligence, big data and other new technologies in the medical device industry.
Collective mining short medical stocks
Collective mining for different medical companies have different impacts, can not be generalized. For some companies, the collection may be a negative, while for others, it may be an opportunity.
On the one hand, the collection can reduce the profit margins of medical companies, for example, for some medical devices and medicines, which may be negatively affected by the collection because of the large room for price reductions. On the other hand, for some healthcare service providers, such as medical aesthetics, medical checkups and medical consulting, the implementation of centralized procurement may increase the market demand for these services, thus bringing opportunities for these companies.
In short, the impact of centralized purchasing is different for different healthcare companies. However, whether it is a negative impact or an opportunity, companies should focus on their own operations and service quality, and improve their competitiveness to cope with market changes.
Leading non-collective medical device stocks
Leading non-collective medical device stocks are:
___Warner Gene (300676).
__Yuyue Medical (002223). __ Kangtai biological (300601). __Weiguang Bio (002880). __Mike Bio (300463). ___Archidon Medical (603589). __Chunli Medical (301206). __BaoLite (300248). __Ribon Instruments (300206).
These stock investment value may change with market changes, investment should be cautious.
This is the end of the introduction of the conceptual stocks of medical device procurement.